Status:
COMPLETED
Studies of Apolipoprotein Genotyping on the Drug Treatment of Hyperlipidemic Patients
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Hyperlipidemia
Eligibility:
All Genders
18+ years
Brief Summary
Cardiovascular-related diseases have been the majorities of the leading ten causes of death in Taiwan. Atherosclerotic cardiovascular diseases are multifactorial. Some non-modifiable risk factors (e.g...
Detailed Description
Cardiovascular-related diseases have been the majorities of the leading ten causes of death in Taiwan. Atherosclerotic cardiovascular diseases are multifactorial. Some non-modifiable risk factors (e.g...
Eligibility Criteria
Inclusion
- Hyperlipidemia
Exclusion
- Liver and kidney disease
Key Trial Info
Start Date :
January 1 2002
Trial Type :
OBSERVATIONAL
End Date :
January 1 2005
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT00451464
Start Date
January 1 2002
End Date
January 1 2005
Last Update
March 23 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pan-Chyr Yang
Taipei, Taiwan, 100